Pharmacokinetics of moxalactam in patients with renal failure and during hemodialysis.
The pharmacokinetics of moxalactam were determined in eight patients with end stage renal disease who were undergoing chronic hemodialysis. The mean half-life of moxalactam in the interdialysis period was 19 h, with a range of 9 to 30 h. The mean half-life of moxalactam during dialysis was 4 +/- 0.5...
Tallennettuna:
| Julkaisussa: | Antimicrob Agents Chemother |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology (ASM)
1981
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181708/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6458236/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.20.3.398 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|